Goldman Sachs: “They expect to supply globally up to 50mn vaccine doses in 2020 and manufacture up to 1.3bn doses in 2021. Based on PFE/BNTX dosing schedule each person will require two doses.PFE noted on the company’s 3Q earnings call that they expect to provide 30-40mn doses in the US by the end of 2020 assuming they receive approval and the vaccine is distributed by the government. They expressed confidence in their ability to supply 100mn doses to the US by March 2021”